MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Dual device aided therapy for patients with advanced Parkinson’s Disease: A case series

    A. Faust- Socher, G. Yahalom, M. Kestenbaum, A. Hilel, S. Israeli-Korn, A. Thaler, H. Strauss, H. Shabtai, S. Hassin-Baer, N. Giladi, T. Gurevich, O. Cohen (Tel Aviv, Israel)

    Objective: To describe the benefits of adding levodopa–carbidopa intestinal gel infusion (LCIG) therapy to Parkinson’s disease (PD) patients on deep brain stimulation (DBS). Background: Device-aided…
  • 2018 International Congress

    Remotely supervised home-based aerobic exercise for Parkinson patients

    N. vd Kolk, N. de Vries, B. Post, B. Bloem (Nijmegen, Netherlands)

    Objective: To evaluate: (1) the adherence to long-term home-based aerobic exercise (AE) in patients with Parkinson’s disease (PD); and (2) whether AE affords clinically relevant…
  • 2018 International Congress

    The complementary relationship between zonisamide and istradefylline in treating patients with Parkinson’s disease

    T. Kadowaki, M. Hamaguchi, H. Sakuramoto, T. Shiina, H. Fujita, K. Suzuki, K. Hirata (Mibu, Japan)

    Objective: To investigate patients with Parkinson’s disease (PD) who received zonisamide and istradefylline at the same period. Background: Zonisamide and istradefylline are anti-PD drugs with…
  • 2018 International Congress

    The course of Parkinson’s disease in patients with impaired carbohydrate metabolism

    F. Akhmedova, B. Shagazatova, D. Artikova, F. Mirxaydarova (Tashkent, Uzbekistan)

    Objective: To study the state of lipid metabolism in PD patients with concomitant type 2diabetes (with different glucose tolerance and the effect of DA agonist…
  • 2018 International Congress

    A randomized double-blind placebo-controlled trial of probiotics for constipation in Parkinson’s disease

    K.K. Chong, S.Y. Lim, M.A.A. A Manap, J.L. Lim, S.C. Low, S. K Mahadeva, A.H. Tan (Kuala Lumpur, Malaysia)

    Objective: To investigate the effects of probiotics on constipation in PD, using a randomized controlled trial (RCT) design Background: Non-motor symptoms (NMS) cause significant disability…
  • 2018 International Congress

    Frequency-dependent effects of subthalamic deep brain stimulation on motor symptoms in Parkinson’s disease

    D. Su, W. Hu, H. Chen, J. Zhou, T. Feng (Beijing, China)

    Objective: This study aims to investigate whether low-frequency stimulation (LFS) (100Hz, mostly 130 or 150 Hz) in deep brain stimulation (DBS) targeting subthalamic nucleus (STN).…
  • 2018 International Congress

    Changes in chest wall intermuscular coherence and speech breathing kinematics during speech and non-speech tasks following LSVT LOUD® in children with dysarthria secondary to cerebral palsy

    M. Ho, A. Reed, B. Mager, H. Gynane, R. Bakhtiari, C. Fox, C. Boliek (Edmonton, AB, Canada)

    Objective: The present study examined the short- and long-term treatment effects of Lee Silverman Voice Treatment (LSVT LOUD) on respiratory control via lung volume events…
  • 2018 International Congress

    Chinese patients with Wilson disease and the treatments: exampled with Unithiol (DMPS) intravenous infusion

    X.P. Wang (Shanghai, China)

    Objective: The authors performed a retrospective analysis about effects and side-effects for a series of 136 Chinese patients with Wilson disease, treated by Unithiol (DMPS)…
  • 2018 International Congress

    The first case of Perry syndrome in Estonia

    K. Vender, T. Toomsoo, I. Kalju, I. Rubanovits, K. Joost, P. Taba (Tallinn, Estonia)

    Objective: Perry syndrome is an autosomal dominant disorder characterized by progressive parkinsonism and central hypoventilation. Background: Since the original publication in 1975 there have been…
  • 2018 International Congress

    Deep brain stimulation for choreoathetosis in cerebral palsy: Pallidal versus thalamic stimulation

    M. Wolf, C. Blahak, A. Saryyeva, C. Schrader, J. Krauss (Mannheim, Germany)

    Objective: We aimed to assess, whether the thalamic ventral intermediate nucleus (Vim) might be an alternative target for DBS in choreoathetosis. Background: Choreoathetosis is common…
  • « Previous Page
  • 1
  • …
  • 23
  • 24
  • 25
  • 26
  • 27
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley